Answers are grounded in this paper and cite their sources.
Aminoglycosides continue to be widely used for the treatment of serious Gram-negative infections. Ten to fifteen per cent of all courses of therapy are complicated by declines in renal function, despite close monitoring of serum drug levels. The proposed pathogenesis and biochemical mechanisms of renal dysfunction caused by these commonly used therapeutic agents are discussed.
No takes yet. Share an insight, caveat, or question.
William M. Bennett (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: